Anti-CD19 CAR T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and NHL

NCT03373071 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

CD19-ALL
CD19-LNH

Interventions

BIOLOGICAL: CD19-CAR T cell

Sponsor

Bambino Gesù Hospital and Research Institute